TRANSDERMAL DRUG DELIVERY ARTICLES

eye drops-GettyImages-1406386094 FDA Seeks Comment On Quality Considerations For Topical Ophthalmic Drug Products Draft Guidance

As a response to recent observations regarding the contamination of eye drops, the FDA published draft guidance titled Quality Considerations for Topical Ophthalmic Drug Products on Oct. 13, 2023. In addition to addressing quality considerations, the guidance also provides recommendations about the CMC documentation. The deadline for submitting public comments is Dec. 12, 2023.

TRANSDERMAL DRUG DELIVERY RESOURCES

TRANSDERMAL DRUG DELIVERY SOLUTIONS